Back to Careers

‘Insulin for muscle’ and the AI platform behind it, with CEO Dr. Hanadie Yousef

Back to Careers

Who Are Today’s Biotech Underdogs and What Will It Take for Them to Succeed?

Back to Careers

Weight Loss for Longevity? How Metabolic Drugs are Disrupting Chronic Disease and Improving Healthspan

Back to Careers

Pharmaceutical Executive Video Interview: Hanadie Yousef, PhD, Co-Founder and CEO Juvena Therapeutics, Inc. (Link to 5 video clips)

Watch all 5 clips now:

Expanding Disease Indications JUV161

Obesity Muscle Targeting Program

Weight Loss Without Loss Of Muscle Strength / Function

JUV161 Phase 1

Potential Synergy Between Obesity Myopathies

Back to Careers

CEO Dr. Yousef represents Juvena as a Technology Pioneer at at the World Economic Forum’s Annual Meeting of the New Champions, a.k.a. Summer Davos, in Dalian, China, speaking on “Revolutionary Remedies” and “Letting Biotech Breath”

Back to Careers

CEO Dr. Hanadie Yousef represents Juvena on 2 panels at BIO San Diego to discuss navigating the frontiers of First-in-Class therapeutics, and how healthspan promoting therapeutics are entering the biopharma mainstream

Back to Careers

Longevity Technology highlights Juvena and others from the Longevity Summer Dublin

Back to Careers

AFAR: AI For Longevity Drug Discovery: Breakthrough and Challenges Webinar